Call for Proposals - 2020 ISPE Annual Meeting & Expo

Driving the Future of Pharma

The 2020 ISPE Annual Meeting & Expo will focus on aligning the future of pharmaceutical science and manufacturing as the industry becomes more global, synchronized, digitalized, and quality-driven. This signature event draws pharmaceutical and biopharmaceutical professionals at all levels of the industry from students and young professionals to the most senior executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies.

Submit Proposal

Proposal Guidelines

Call for Proposals Timeline

  • Opens: 20 December 2019
  • Submission Deadline: 15 March 2020
  • Committee Review Begins: 16 March 2020
  • Notifications: 20 April 2020

Abstract Submission Types

  • 90-Minute Session
  • 2-Hour Workshop
  • Individual Oral Presentation
  • Poster Presentation

Presentation Guidelines

  • All presentations must be free of commercial intent.
  • Incomplete proposals will not be considered.
  • By submitting a proposal, you acknowledge that, if your proposal is accepted, your organization will support your attendance at the conference.
  • Accepted Annual Meeting session leaders and speakers are responsible for their own travel and accommodations.
  • Session leaders and speakers giving a full (25-minute or longer) presentation receive complimentary conference registration for the day on which their session is scheduled.
  • Co-Session Leaders, Co-Speakers, Panelists or Poster Presenter who are not giving a full presentation receive a 20% discount on conference registration. NOTE: Exhibitors who are accepted to present a poster will be required to register as a paid conference attendee (with 20% discount off prevailing registration rate). Complimentary booth staffing registrations cannot be utilized for poster presentations as these are part of the education sessions and not the exhibition.
  • Interested leaders and speakers may purchase full conference registration at a discounted rate.

Speaker Package Rates

Before 3 July 3 July – 20 Sep After 20 Sep
$1,328 $1,528 $1,728

Requested Submission Topics

  • Facilities and Equipment

    Track Directors:

    Principal Engineer Facilities and Utilities
    Sanofi
    Placeholder Person Graphic
    Director of Operations
    CAI

    The Future of Facilities and Equipment – Innovative Designs and Cutting-Edge Solutions

    This track is designed to inform attendees on options to design, build and qualify modern and efficient facilities and equipment used to support the development, manufacturing, testing, storage and distribution of therapeutic products today and into the future. As speed to market and breakthrough therapies continue to reshape the landscape, there is even more need to apply a harmonized approach to innovative design solutions and project delivery strategies. Each product component and the product itself create unique challenges for facility design, equipment selection and overall project execution. How these challenges are addressed will ensure that quality therapeutic products are brought to market in an efficient manner in order to improve patient health. The emphasis of the topics presented by the F&E Track has been arranged to provide Owners/ Users/ Designers – whose experiences, wants and needs are invaluable – with modern-day examples of how to modernize, harmonize, and transform the facilities and products of the future.

    • Cell and Gene Therapy Facilities
    • Approaches for design and project delivery for breakthrough therapies
    • Consideration of reliability and sustainability impacts
    • Application of QRM to the C&Q process to ensure facilities and equipment fit for their intended purpose
    • Managing regulatory assessments of new facilities

    Communities of Practice/Special Interest Groups:

    API, Biotechnology, Commissioning & Qualification, Critical Utilities, GAMP®, HVAC/Sustainable Facilities, Oral Solid Dosage, Project Management, Sterile Products Processing

  • Information Systems

    Track Directors:

    Senior Director Global Accounts
    Werum IT Solutions
    Informatics Specialist
    Eli Lilly and Company

    Holistic Digitalization of the Artificial Intelligent Smart Factory – Pharma 4.0

    The digitalization and the management of big data and its analytics enables not only the control, but also the prediction and optimization of all related business processes. This disruptive change from retrospective control to predictive control is enabled by big data management and the data integrity by design approach. The Digitalization of the pharmaceutical industry coming with the ISPE Pharma 4.0 Operating Model and the Smart Manufacturing approach results in disruptive changes in Information Systems (IS) design and lifecycle management. The new digital ICH Q10 Pharmaceutical Quality Systems / PQS enablers Digital Maturity and Data Integrity by Design need new design concepts, enabling inspection readiness. The PQS Digitalization Element Information Systems has a key role in the Digitalization of the AI Smart Factory. This includes the end-to-end ICH based pharmaceutical lifecycle management from Development, Clinical, Tech Transfer, Scale Up to Commercial Manufacturing streamlining the manufacturing supply chain.

    • Digitalization Strategies, Concepts and Case Studies
    • Practical Experiences in Data Integrity by Design and DI Inspection Readiness
    • Practical Experiences in achieving Digital Maturity
    • Clinical/R&D Systems digitalization
    • Technologies & Devices in Biotech, Cell & Gene, ATMPs
    • Smart Digital Health Devices

    Communities of Practice/Special Interest Groups: GAMP®, Pharma 4.0, Oral Solid Dosage, Supply Chain, Operations, & Packaging, Data Integrity, Blockchain, AI, MES, PAT & Lifecycle Control Strategy

  • Innovation in Pharmaceutical Manufacturing

    Track Director:

    Director of Engineering and Facilities
    Emergent BioSolutions
    EMEA Major Project Planning Leader, Global Engineering
    Eli Lilly SA Irish Branch

    New Frontiers in Medicine – Innovative Technologies and Applications

    The innovation forum will focus on emerging and evolving technologies that are helping drive a revolution in medicinal therapies, analytical techniques, manufacturing paradigms, medical devices including novel methods to deliver the next generation of drugs to patients. The intent of this track is to highlight the global Pharmaceutical industry’s challenges, recent innovations, opportunities and success stories relative to the discovery and adoption of emerging technologies for pharmaceutical applications. This forum seeks to highlight innovations in small molecule, biopharmaceutical (large molecule) as well as whole cell and tissue engineering. The focus is on the full lifecycle of therapeutic production : early drug substance production to final drug product and the patient experience. Regulatory perspectives on the key challenges and opportunities for the adoption of these technologies will also be in scope for the innovation forum sessions. Novel approaches that will improve the sustainability / global social responsibility of the sector are welcome as are operational excellence examples that improve efficiency. Bioprinting

    • Adoption of Pharma 4.0 including Artificial Intelligence (AI) by Pharma and Biotech
    • New Developments in Antibiotics and Vaccines including their commercialization for emerging markets
    • Advanced Therapy Medicinal Products (ATMPs) and Cell and Gene Therapies
    • Biomanufacturing: Process improvements and advances including single-use systems and closed processing
    • Advances in robotics and convergent technologies such as 3D printing in the Pharmaceutical industry
    • Novel trends in drug and smart delivery devices
    • Innovative approaches to the sustainable supply of medicines
    • Next Generation approaches to Continuous Processing

    Communities of Practice/Special Interest Groups: All

  • Process Development & Manufacturing

    Track Directors:

    GMS - Director Global API Technology
    Zoetis
    Managing Consultant , Compliance Consulting
    NNE

    Innovations in Process Development and Manufacturing - Driving the Future State

    Novel therapies are leading us to reassess the way we develop and manufacture drug substances and drug products. The track will explore the business strategies and technology aspects associated with the future state of manufacturing. This includes transition to continuous processing to streamline process development, minimize manufacturing footprint and provide supply flexibility. Utilizing plug and play equipment for an agile approach to process development and manufacturing. Integration of data analytics and process control to define process capability and robustness. If you are involved in any aspect of drug substance and drug product development and manufacturing (Quality, Regulatory, Technical, Project Management, Equipment, EHS or Supply Chain) you should plan to attend this session to share best practices and benchmark solutions which will enable the future state of process development and manufacturing.

    • Continuous Manufacturing for API and Drug Product
    • Flexible/Agile Laboratory and Manufacturing Environments
    • Manufacturing Technologies for Personalized Medicines
    • API/Drug Product Interface
    • Ensuring Process Capability/Product Robustness
    • Process Control and Integrated Data Analytics in Manufacturing
    • Technology Transfer
    • Knowledge Management

    Communities of Practice/Special Interest Groups: Regulatory, Information Systems, Knowledge Management, Sterile Products Processing, Containment, Biotechnology, Oral Solid Dosage, PAT and Lifecycle Control Strategy, Process/Product Development

  • Quality Systems & Regulatory

    Track Directors:

    Senior Director, Global Regulatory Affairs
    AstraZeneca
    Director, Enterprise Regulatory Compliance
    J&J Corporate

    More information coming soon!

  • Supply Chain, Operations, & Packaging Excellence (SCOPE)

    Track Directors:

    CEO
    PTI Inspection Systems
    Senior Director, Validation Services
    IPS-Integrated Project Services, LLC

    SCOPE: Meeting Operational and Packaging Challenges of the Future

    The Supply Chain, Operations and Packaging Excellence (SCOPE) track will focus on the operational, supply chain and packaging challenges that have arisen during a period of intense technological advances. The sessions in this track will highlight the latest processes and how they have presented new and unique challenges to the operations and packaging managers and personnel. In addition, there will be sessions that look into some of the rising technologies and look to anticipate the operational challenges while providing potential solutions to those potential pitfalls.

    • Personalized medicine
    • Cell and Gene Therapy
    • Unique Drug Delivery Systems
    • 3D Printing
    • Nanotechnology
    • Cold Chain
    • Next Generation Packaging Solutions

    Communities of Practice/Special Interest Groups: Engineering, GAMP®, Operations Management, Packaging, Novel Technologies

 


Submit Proposal